Table 2.
BSI Type or Outcome | Patients With BSI by Infection Source, No. % | |||||||
---|---|---|---|---|---|---|---|---|
Overall (N = 562) | Abdominal (n = 189) | Urinary Tract (n = 138) | Unidentified (n = 132) | Central Catheter (n = 47) | Respiratory Tract (n = 33) | SSTI (n = 12) | Multiple Sources (n = 7) | |
Hospital acquired | 161 (29) | 39 (21) | 27 (20) | 50 (38) | 21 (45) | 18 (55) | 2 (17) | 3 (43) |
MDR | 87 (16) | 21 (11) | 28 (20) | 15 (11) | 8 (17) | 10 (30) | 2 (17) | 2 (29) |
ESBL phenotype | 112 (20) | 29 (15) | 32 (23) | 22 (17) | 10 (21) | 12 (36) | 4 (33) | 2 (29) |
Hardware | 185 (33) | 86 (46) | 42 (30) | 0 (0) | 47 (100) | 7 (21) | 0 (0) | 3 (43) |
ICU admission | 207 (37) | 56 (30) | 39 (28) | 54 (41) | 17 (36) | 28 (85) | 7 (58) | 4 (57) |
Hospital death | 81 (14) | 23 (12) | 13 (9) | 20 (15) | 3 (6) | 17 (52) | 3 (25) | 2 (29) |
Abbreviations: BSI, bloodstream infection; ESBL, extended-spectrum β-lactamase; ICU, intensive care unit; MDR, multidrug resistance; SSTI, skin and soft-tissue infection.